URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION

NEUROLOGY

LIPPINCOTT WILLIAMS & WILKINS

1. MRC [G90/63, G0800674] Funding Source: UKRI
2. Medical Research Council [G0800674, G90/63] Funding Source: Medline
3. Wellcome Trust [084980, 074454] Funding Source: Medline
4. Medical Research Council [G0601943B, G90/63] Funding Source: researchfish